Biolexis Therapeutics, Inc.
PrivateLast Round
Seed Round
Jun 3, 2026
Total Funding Raised
$13.98M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biolexis Therapeutics, Inc. is a biotechnology company that utilizes a proprietary AI-enabled platform for the discovery and development of small molecule therapeutics for metabolic, inflammatory, and other chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolexis Therapeutics, Inc. Comparables
Compare Biolexis Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ambrosia Biosciences Inc. | 83% | |
| Syntis Bio, Inc. | 82% | |
| Verdiva Bio | 81% |
Biolexis Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 3, 2026 | ||||
| Series A | Nov 22, 2023 | ||||
| Seed | Oct 3, 2023 | ||||
| Seed | Sep 2, 2022 | ||||
| Debt | Feb 14, 2022 |
Biolexis Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Clarke Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 427% MoM, from 280 to 1.5K.
- Jun 3, 2026
$1.6M raised in Seed Round funding.
Biolexis Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biolexis Therapeutics, Inc.'s valuation, stock price, and market status.
Is Biolexis Therapeutics, Inc. a public or private company?
Biolexis Therapeutics, Inc. is a private company.
What is the current stock price of Biolexis Therapeutics, Inc.?
Biolexis Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Biolexis Therapeutics, Inc. worth (valuation)?
Valuation information for Biolexis Therapeutics, Inc. is not publicly available.
Can I buy Biolexis Therapeutics, Inc. stock?
Biolexis Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biolexis Therapeutics, Inc.'s last funding round?
Biolexis Therapeutics, Inc.'s most recent funding round was Seed Round on June 3, 2026.
Who are the main investors in Biolexis Therapeutics, Inc.?
Investor information for Biolexis Therapeutics, Inc. is not publicly disclosed.
Will Biolexis Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Biolexis Therapeutics, Inc..
How can I track Biolexis Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biolexis Therapeutics, Inc.'s secondary market activity and sign up for updates.